ภาควิชากุมารเวชศาสตร์ | คณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล

31.

Ding J, Mairiang D, Prayongkul D, Puttikhunt C, Noisakran S, Kaewjiw N, Songjaeng A, Prommool T, Tangthawornchaikul N, Angkasekwinai N, Suputtamongkol Y, Lapphra K, Chokephaibulkit K, White NJ, Avirutnan P, Tarning J.

In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever
CPT Pharmacometrics Syst Pharmacol. 2024.

32.

Nimkar S.; Kinikar A.; Mave V.; Khol V.; Du Q.T.; Nguyen L.; Ounchanum P.; Nguyen D.Q.; Puthanakit T.; Kosalaraks P.; Chokephaibulkit K.; Sudjaritruk T.; Muktiarti D.; Kumarasamy N.; Yusoff N.K.N.; Mohamed T.; Wati D.; Alam A.; Fong S.; Nallusamy R.; Suwanlerk T.; Sohn A.; Kariminia A.; Ly P.S.; Penh P.; Tucker J.; Kumarasamy N.; Chandrasekaran E.; Kinikar A.; Mave V.; Marbaniang I.; Wati D.K.; Vedaswari D.; Ramajaya I.B.; Ngoerah I.G.N.G.; Kurniati N.; Mangunkusumo C.; Fong S.M.; Lim M.; Daut F.; Yusoff N.K.N.; Mohamad P.; Mohamed T.J.; Drawis M.R.; Nallusamy R.; Chan K.C.; Sudjaritruk T.; Sirisanthana V.; Aurpibul L.; Hansudewechakul R.; Denjanta S.; Kongphonoi A.; Lumbiganon P.; Kosalaraksa P.; Tharnprisan P.; Udomphanit T.; Jourdain G.; Puthanakit T.; Anugulruengkit S.; Jantarabenjakul W.; Nadsasarn R.; Chokephaibulkit K.; Lapphra K.; Phongsamart W.; Sricharoenchai S.

Long-term risk of mortality and loss to follow-up in children and adolescents on antiretroviral therapy in Asia
HIV Medicine. 2024.

33.

Prasanchaimontri I.-O.; Manosuthi W.; Pertinez H.; Owen A.; Niyomnaitham S.; Sirijatuphat R.; Charoenpong L.; Cressey T.; Copeland K.; Mokmued P.; Chokephaibulkit K.

Favipiravir pharmacokinetics in Thai adults with mild COVID-19: A sub-study of interpatient variability and ethnic differences in exposure
Pharmacology Research and Perspectives. 2024. 12 (6):

34.

Buaboonnam J, Rungmaitree S, Piyaphanee N, Charuvanij S, Pitisuttithum O, Copeland K, Pheerapanyawaranun C, Jansarikit L, Niyomnaitham S, Chokephaibulkit K.

Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study
Human Vaccines and Immunotherapeutics. 2024. 20 (1):

35.

Chokephaibulkit K, Huoi C, Tantawichien T, Mootsikapun P, Kosalaraksa P, Kiertiburanakul S, Ratanasuwan W, Vangelisti M, Laot T, Huang Y, Petit C, Pineda-Peña AC, Frago C.

Non-inferiority study of purified Vero rabies vaccine - serum free in three-dose and two-dose pre-exposure prophylaxis regimens in comparison with licensed rabies vaccines
Clin Infect Dis. 2024.

36.

Aurpibul L., Kosalaraksa P., Kawichai S., Lumbiganon P., Ounchanum P., Natalie Songtaweesin W., Sudjaritruk T., Chokephaibulkit K., Rungmaitree S., Suwanlerk T., Ross J.L., Sohn A.H., Puthanakit T., Thai PAPAYA study team

Alcohol use, suicidality and virologic non-suppression among young adults with perinatally acquired HIV in Thailand: a cross-sectional study
Journal of the International AIDS Society. 2023. 26 (2):

37.

Angkasekwinai N., Prawjaeng J., Leelahavarong P., Khuntha S., Pheerapanyawaranun C., Chitpim N., Srinonprasert V., Chokephaibulkit K.

Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis
Asian Pacific journal of allergy and immunology. 2023. 40 (4): 321-336.

38.

Niyomnaitham S., Atakulreka S., Wongprompitak P., Copeland K.K., Toh Z.Q., Licciardi P.V., Srisutthisamphan K., Jansarikit L., Chokephaibulkit K.

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations
Frontiers in Immunology. 2023. 13

39.

Wilck M.; Barnabas S.; Chokephaibulkit K.; Violari A.; Kosalaraksa P.; Yesypenko S.; Chukhalova I.; Dagan R.; Richmond P.; Mikviman E.; Morgan L.; Feemster K.; Lupinacci R.; Chiarappa J.; Madhi S.A.; Bickham K.; Musey L.

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
AIDS. 2023. 37 (8): 1227-1237.

40.

Hanprom J., Lapphra K., Tontiwattanasap W., Papwijitsil R., Copeland K., Chokephaibulkit K.

Case Report: Reemerging Paragonimiasis in Umphang District, Thailand
The American journal of tropical medicine and hygiene. 2023. 108 (4): 738-743.

ผลงานที่ได้รับการตีพิมพ์